This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
protein
product name :
Recombinant Human S100A2, Fc tagged
catalog :
S100A2-842H
product information
Cat :
S100A2-842H
Product Name :
Recombinant Human S100A2, Fc tagged
Brand :
Creative Biomart
gene symbal :
S100A2
gene name :
S100 calcium binding protein A2
Synonyms :
S100A2; S100 calcium binding protein A2; S100 calcium binding protein A2 , S100L; protein S100-A2; CAN19; S100 calcium-binding protein A2; S100L; MGC111539
Product Overview :
Recombinant Human S100A2 (NP_005969.1) (Met 2-Pro98), fused with the Fc region of human IgG1 at the N-terminus, was produced in Human Cell.
Description :
Recombinant Human S100A2 (NP_005969.1) (Met 2-Pro98), fused with the Fc region of human IgG1 at the N-terminus, was produced in Human Cell.
Source :
Human Cells
Form :
Lyophilized from sterile 100mM Glycine, 10mM NaCl, 50mM Tris, pH 7.5
Storage :
Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
UniProt ID :
P29034
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments